miR-629 Targets TRIM33 to Promote TGF /Smad Signaling and Metastatic Phenotypes in ccRCC

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-14-0300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

G3BP1 Activates the TGF-β/Smad Signaling Pathway to Promote Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

SALL4 Activates TGF-β/SMAD Signaling Pathway to Induce EMT and Promote Gastric Cancer Metastasis

Cancer Management and Research
Oncology
2018English

Non-Degradative Ubiquitination in Smad-Dependent TGF-beta Signaling

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2011English

New Insights Into TGF-β/Smad Signaling in Tissue Fibrosis

Chemico-Biological Interactions
MedicineToxicology
2018English

Long Noncoding RNA ELIT-1 Acts as a Smad3 Cofactor to Facilitate TGF-β/Smad Signaling and Promote Epithelial-Mesenchymal Transition

Cancer Research
Cancer ResearchOncology
2019English

miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2013English

TGF-β Upregulates miR-181a Expression to Promote Breast Cancer Metastasis

Journal of Clinical Investigation
Medicine
2012English

MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient Survival

PLoS ONE
Multidisciplinary
2013English

Requirements of Transcription Factor Smad-Dependent and -Independent TGF- Signaling to Control Discrete T-Cell Functions

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy